Onderneming Horizon Therapeutics Public Limited Company
Aandelen
HZNP
IE00BQPVQZ61
Farmaceutische producten
Vakgebied
Aantal werknemers: 2 190
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01-06-08 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 01-04-16 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 02-11-20 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-07-14 |
Chief Tech/Sci/R&D Officer | 66 | 01-10-16 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-06-09 |
Keli Walbert
SAM | Sales & Marketing | - | 01-01-18 |
Comptroller/Controller/Auditor | 45 | 01-02-15 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01-06-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 229 378 934 | 226 691 767 ( 98,83 %) | 384 366 ( 0,1676 %) | 98,83 % |
Bedrijfsgegevens
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 653 mld. | |
+27,00% | 556 mld. | |
-6,76% | 354 mld. | |
+20,34% | 331 mld. | |
+3,00% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-6,26% | 144 mld. |